Table 4 Frequency of cancer in male and female PMS2 carriers
From: PMS2 mutation spectra in Norway and risk of cancer for carriers of pathogenic variants
Cancer | All (n = 482) | Women (n = 262) | Men (n = 220) |
|---|---|---|---|
Colorectum | 87 (18.0%) | 36 (13.7%) | 51 (23.8%) |
Endometrium | - | 32 (12.2%) | |
Ovary | - | 5 (1.9%) | |
Prostate | - | 8 (3.6%) | |
Urinary tract | 1 (0.2%) | 1 (0.4%) | - |
Breast | - | 17 (6.5%) |